EUVIMEDEUVIMED entdecken
Crossref

26-A-21088-ACC COMPARATIVE EFFICACY OF PCSK9 INHIBITORS VS BEMPEDOIC ACID AMONG PATIENTS WITH ASCVD WITHOUT DIABETES : A REAL WORLD ANALYSIS

Abdul-Rahaman Adedolapo Ottun, Efeturi Maxwell Okorigba, Christopher S. Chinnatambi, Baffour Otchere, Brice Njobe, Jorge Pimentel, Wael Kanjo

JACC · 2026-04 · 87 (13) · A287

DOI: 10.1016/j.jacc.2026.02.710 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Abdul-Rahaman Adedolapo Ottun und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ottun, A. A., Okorigba, E. M., Chinnatambi, C. S., Otchere, B., Njobe, B., Pimentel, J., & Kanjo, W. (2026). 26-A-21088-ACC COMPARATIVE EFFICACY OF PCSK9 INHIBITORS VS BEMPEDOIC ACID AMONG PATIENTS WITH ASCVD WITHOUT DIABETES : A REAL WORLD ANALYSIS. JACC, 87(13), A287. https://doi.org/10.1016/j.jacc.2026.02.710

Vancouver

Ottun AA, Okorigba EM, Chinnatambi CS, Otchere B, Njobe B, Pimentel J, et al. 26-A-21088-ACC COMPARATIVE EFFICACY OF PCSK9 INHIBITORS VS BEMPEDOIC ACID AMONG PATIENTS WITH ASCVD WITHOUT DIABETES : A REAL WORLD ANALYSIS. JACC. 2026;87(13):A287. doi:10.1016/j.jacc.2026.02.710

BibTeX
@article{Ottun2026,
  author = {Ottun, Abdul-Rahaman Adedolapo and Okorigba, Efeturi Maxwell and Chinnatambi, Christopher S. and Otchere, Baffour and Njobe, Brice and Pimentel, Jorge and Kanjo, Wael},
  title = {26-A-21088-ACC COMPARATIVE EFFICACY OF PCSK9 INHIBITORS VS BEMPEDOIC ACID AMONG PATIENTS WITH ASCVD WITHOUT DIABETES : A REAL WORLD ANALYSIS},
  journal = {JACC},
  year = {2026},
  volume = {87},
  number = {13},
  pages = {A287},
  doi = {10.1016/j.jacc.2026.02.710}
}
Kostenlos starten →